Advertisement

CHMP

EU’s CHMP Recommends Evusheld by Astrazeneca for Use in Treating COVID-19

September 16th, 2022|Categories: Featured, Industry News|Tags: , , , , |

Astrazeneca has received a conditional recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for its COVID-19 treatment Evusheld. The treatment contains two antibodies against the SARS-CoV-2 virus produced by donated B-cells from people who’ve had COVID-19 in the past.

Quick Links

Our Company

Privacy Policy

Advertising & Marketing Services


ABOUT US

HealthEconomics.com is the world’s largest digital Connected Community™ for Value, Evidence and Access in the life sciences industry. HealthEconomics.com provides professionals within the health economic and outcomes research (HEOR), real-world evidence (RWE) and Market Access (MA) communities a single global link to industry insights and news, market reports and more. Since the beginning, we have provided unparalleled access to help our stakeholders drive business, improve knowledge and connect researchers and payer decision-makers worldwide.

SCIENTIST.COM FAMILY

Scientist.com is a privately-held, San Diego-based company on a mission to empower and connect scientists and make it faster and cheaper to discover new medicines. At its heart is an AI-powered marketplace for complex research experiments with the potential to transform the pharmaceutical industry in the same way Amazon has transformed the retail industry. The marketplace helps drug researchers use innovative technologies to rapidly translate their ideas into actionable data. Scientist.com’s clients include most of the world’s largest pharmaceutical companies, 100+ biotechs and the US National Institutes of Health. Through Scientist.com, these clients communicate directly with research experts at over 4,000 global laboratories to design and execute complex research experiments.

Learn more at Scientist.com.

© Copyright | HealthEconomics.Com - A Scientist.com Company | All Rights Reserved
LinkedInTwitterFacebookVimeo
Cookies help us deliver our services and optimize website experience. By continuing to browse this domain, you accept our terms and conditions and privacy policy. Read our privacy policy Accept
Go to Top